DRDO To Release First Batch Of 10,000 Anti-Covid Drug 2-DG Today

<p><strong>New Delhi:</strong> On Monday, the first batch of anti-COVID drug 2-DG, developed by the DRDO, will be released by Defence Minister Rajnath Singh and Health Minister Harsh Vardhan. Around 10,000 doses will be distributed to some hospitals in the national capital.</p> <p>The drug developed by the Institute of Nuclear Medicine and Allied Sciences (INMAS) which is a lab of the Defence Research and Development Organisation (DRDO), in collaboration with Dr Reddy's Laboratories (DRL), Hyderabad.</p> <p><strong>ALSO READ: <span style="color: #f80707;"><a style="color: #f80707;" href="https://ift.tt/3hCZdEu Navneet Kalra Accused In Black Marketing Of Oxygen Concentrators Arrested: Delhi Police Sources</a></span></strong></p> <p>The DGCI the oral drug, drug 2-deoxy-D-glucose (2-DG), for emergency use as an adjunct therapy in moderate to severe coronavirus patients, the defence ministry said earlier this month. The approval of the drug has come at a time when India is grappling with a record-breaking wave of the coronavirus pandemic that has stretched the country's healthcare infrastructure to its limit.</p> <p>On May 8, said the clinical trials of the drug, 2-deoxy-D-glucose (2-DG), showed that it helps in a faster recovery of hospitalised patients and reduces supplemental oxygen dependence.<br /><br /><br /></p>

from covid-19 https://ift.tt/3fkPTTb